Top Markets
Coin of the day
ReShape Lifesciences Inc. ReShape Lifesciences Inc.

ReShape Lifesciences Inc.

RSLS
Clasificación en acciones #36770
Founded in 2002 and based in San Clemente, California, ReShape Lifesciences... Founded in 2002 and based in San Clemente, California, ReShape Lifesciences Inc. operates as a medical device company dedicated to addressing obesity and metabolic diseases. The company's market extends throughout the United States, Australia, Europe, and globally. Its diverse product lineup features the Lap-Band System, a minimally invasive, long-term solution for severe obesity that offers an alternative to more extensive surgical interventions like gastric bypass or sleeve gastrectomy. Under development is the ReShape Vest system, an investigational, minimally invasive device that is laparoscopically implanted around the stomach to assist obese and morbidly obese patients in losing weight, without cutting or permanently removing parts of the stomach or bypassing any section of the gastrointestinal tract. ReShape also supports patients through the ReShapeCare virtual health coaching program, a telehealth service aimed at promoting healthy lifestyle adjustments for individuals undergoing medically supervised weight management. Additionally, the company is conducting preclinical development for ReShape Diabetes Bloc-Stim Neuromodulation, a technology intended for the treatment of type 2 diabetes mellitus. Among its offerings is the Obalon Balloon System, a swallowable capsule used to monitor and display the balloon's exact position during its placement. The company, initially incorporated as EnteroMedics Inc., changed its name to ReShape Lifesciences Inc. in 2017.
Precio por acción
$3.92
Última sincronización: 2025-08-14
Capitalización bursátil
$2.34M
Cambio (1 día)
-69.38%
Cambio (1 año)
0.00%
País
US
Comercio ReShape Lifesciences Inc. (RSLS)

Categoría

Precio RSLS con Capital del mercado a B
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
RSLS
$3.92
Capitalización de mercado de ReShape Lifesciences Inc.(RSLS)
Capitalización bursátil: $2.34M
A fecha de August 2026, ReShape Lifesciences Inc. tiene una capitalización de mercado de $2.34M. Esto convierte a ReShape Lifesciences Inc. en la 36770th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de ReShape Lifesciences Inc. desde 2019 hasta 2026
RSLS en comparación con los más populares 5 títulos stocks
Precio por RSLS Activo B Capital del mercado en B Resultados
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$9,139,571 $2.34M
$5.452T +233,152,220.33%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$7,527,119 $2.34M
$4.490T +192,018,245.26%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$6,977,905 $2.34M
$4.162T +178,007,676.79%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$6,163,061 $2.34M
$3.676T +157,220,840.04%
ReShape Lifesciences Inc. ReShape Lifesciences Inc.
$4,749,344 $2.34M
$2.833T +121,156,629.05%